Regulations.gov document
Appendix 3 - "Summary of January 21 Teleconference with FDA Regarding Colchicine"…
Supporting & Related Material · FDA-2010-P-0614 · posted May 17, 2011
Key facts
| Document ID | FDA-2010-P-0614-0071 |
|---|---|
| Title | Appendix 3 - "Summary of January 21 Teleconference with FDA Regarding Colchicine" - [West-Ward Pharmaceutical Corporation (Arnall Golden Gregory LLP) - Supplement] re FDA-2010-P-0614-0069 |
| Document type | Supporting & Related Material |
| Subtype | SUP-Supplement (Supporting and Related Material) |
| Agency | FDA |
| Docket | FDA-2010-P-0614 |
| Posted | May 17, 2011 |
| Effective date | May 11, 2011 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: